The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO

Clinical Radiology

Volumn 70, Issue 1, 2015, Pages 74-80

  Zhang, D ^a   Fa, H B ^b   Zhou, J T ^b   Li, S ^a   Diao, X W ^a   Yin, W ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICYANO 2 [6 (DIMETHYLAMINO)NAPHTHALENE 2 YL] PROPENE CARBOXYL DERIVATIVE; AMYLOID BETA PROTEIN[1-40]; CONGO RED; FERRIC FERROCYANIDE; FERRIC ION; MANNITOL; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; 2 NAPHTHYLAMINE; 2-(1,1-DICYANOPROPENYL-2-)-6-DIMETHYLAMINONAPHTHALENEY; ACRYLONITRILE; COLORING AGENT; CONTRAST MEDIUM; FERROCYANIDE; MAGNETITE NANOPARTICLE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN DISEASE; BRAIN HISTOLOGY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORMATION; IMAGE ANALYSIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RAT; SENILE PLAQUE; SPECTROFLUOROMETRY; STAINING; SYNTHESIS; THERMOGRAVIMETRY; AMYLOID PLAQUE; ANALOGS AND DERIVATIVES; ANIMAL; CASE CONTROL STUDY; DIAGNOSTIC USE; DISEASE MODEL; HIPPOCAMPUS; METABOLISM; PROCEDURES;

2-NAPHTHYLAMINE; ACRYLONITRILE; ALZHEIMER DISEASE; ANIMALS; CASE-CONTROL STUDIES; COLORING AGENTS; CONGO RED; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FERROCYANIDES; HIPPOCAMPUS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; PLAQUE, AMYLOID; RATS; SPECTROMETRY, FLUORESCENCE;

EID: 84916883729     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2014.09.019     Document Type: Article

References (47)

1. R.A. Sperling, P.S. Aisen, and L.A. Beckett Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
2. L.M. Shaw, H. Vanderstichele, and M. Knapik-Czajka Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
3. J.J. Sabbagh, J.W. Kinney, and J.L. Cummings Alzheimer's disease biomarkers: correspondence between human studies and animal models Neurobiol Dis 56 2013 116 130
4. A.M. Fagan, C.M. Roe, and C. Xiong Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349
5. D.M. Holtzman CSF biomarkers for Alzheimer's disease: current utility and potential future use Neurobiol Aging 32 Suppl. 1 2011 S4 S9
6. P. Scheltens Imaging in Alzheimer's disease Dialogues Clin Neurosci 11 2009 191 199
7. C.D. Smith Neuroimaging through the course of Alzheimer's disease J Alzheimers Dis 19 2010 273 290
8. B. Dubois, H.H. Feldman, and C. Jacova Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746
9. S.M. Landau, D. Harvey, and C.M. Madison Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI Neurobiol Aging 32 2011 1207 1218
10. J.B. Langbaum, K. Chen, and W. Lee Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Neuroimage 45 2009 1107 1116
11. J. Xie, K. Chen, and H.Y. Lee Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells J Am Chem Soc 130 2008 7542 7543
12. S. Laurent, D. Forge, and M. Port Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem Rev 108 2008 2064 2110
13. Y.W. Jun, J.H. Lee, and J. Cheon Chemical design of nanoparticle probes for high-performance magnetic resonance imaging Angew Chem Int Ed Engl 47 2008 5122 5135
14. J.H. Lee, Y.M. Huh, and Y.W. Jun Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging Nat Med 13 2007 95 99
15. A.K. Gupta, and M. Gupta Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 2005 3995 4021
16. Y. Ma, S. Tong, and G. Bao Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy Biomaterials 34 2013 7706 7714
17. E.D. Agdeppa, V. Kepe, and J. Liu 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease Mol Imaging Biol 5 2003 404 417
18. K. Shoghi-Jadid, G.W. Small, and E.D. Agdeppa Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am J Geriatr Psychiatry 10 2002 24 35
19. J. Zhou, H. Fa, and W. Yin Synthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer's disease Mater Sci Eng C Mater Biol Appl 37 2014 348 355
20. H.B. Fa, J.T. Zhou, and D. Zhang Synthesis and optical properties of 4-(2-{[6-(1,1-dicyanoprop-1-en-2-yl) naphthalen-2-yl] (methyl)amino} ethoxy)-4-oxobutanoic acid fluorescent probe for β-amyloid Res Chem Intermed 2013 10.1007/s11164-013-1429-0
21. W.E. Klunk, R.F. Jacob, and R.P. Mason Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay Anal Biochem 266 1999 66 76
22. E.D. Agdeppa, V. Kepe, and J. Liu Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease J Neurosci 21 2001 RC189(1-5)
23. K. Yamada, and T. Nabeshima Animal models of Alzheimer's disease and evaluation of anti-dementia drugs Pharmacol Ther 88 2000 93 113
24. M. Stepanichev, I. Zdobnova, and I. Zarubenko Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25-35) on memory function and hippocampal damage in rat Behav Brain Res 175 2006 352 361
25. S. Haller, V. Garibotto, and E. Kövari Neuroimaging of dementia in 2013: what radiologists need to know Eur Radiol 23 2013 3393 3404
26. C.J. Pérez-Torres, J.O. Reynolds, and R.G. Pautler Use of magnetization transfer contrast MRI to detect early molecular pathology in Alzheimer's disease Magn Reson Med 71 2014 333 338
27. H. Benveniste, G. Einstein, and K.R. Kim Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy Proc Natl Acad Sci USA 96 1999 14079 14084
28. M.A. Lovell, J.D. Robertson, and W.J. Teesdale Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 158 1998 47 52
29. J.F. Poduslo, T.M. Wengenack, and G.L. Curran Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging Neurobiol Dis 11 2002 315 329
30. L. Larbanoix, C. Burtea, and S. Laurent Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease Neurobiol Aging 31 2010 1679 1689
31. J. Yang, Y.Z. Wadghiri, and D.M. Hoang Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging Neuroimage 55 2011 1600 1609
32. M. Rotman, T.J. Snoeks, and L. van der Weerd Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease Drug Discov Today Technol 8 2011 2 4
33. E.D. Agdeppa, V. Kepe, and A. Petri In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2- [(18)F] fluoroethyl) (methyl)amino]-2-naphthyl]ethylidene) malono- nitrile Neuroscience 117 2003 723 730
34. J.F. Poduslo, G.L. Curran, and J.A. Peterson Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain permeability, and in vivo targeting to Alzheimer's disease amyloid plaques Biochemistry 43 2004 6064 6075
35. A. Petiet, M. Santin, and A. Bertrand Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice Neurobiol Aging 33 2012 1533 1544
36. M. Dhenain, B. Delatour, and C. Walczak Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease Magn Reson Med 55 2006 687 693
37. Y.Z. Wadghiri, E.M. Sigurdsson, and M. Sadowski Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging Magn Reson Med 50 2003 293 302
38. M.D. Meadowcroft, J.R. Connor, and M.B. Smith Magnetic resonance imaging and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice J Magn Reson Imaging 29 2009 997 1007
39. H. Scholtzova, Y.Z. Wadghiri, and M. Douadi Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's disease model transgenic mice shown as by micromagnetic resonance imaging J Neurosci Res 86 2008 2784 2791
40. M. Ramakrishnan, T.M. Wengenack, and K.K. Kandimalla Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Aβ42 for magnetic resonance molecular imaging Pharm Res 25 2008 1861 1872
41. L.O. Sillerud, N.O. Solberg, and R. Chamberlain SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain J Alzheimers Dis 34 2013 349 365
42. L. Nichols, V.W. Pike, and L. Cai Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease? Biol Psychiatry 59 2006 940 947
43. M. Higuchi, N. Iwata, and Y. Matsuba 19F and 1H MRI detection of amyloid-plaques in vivo Nat Neurosci 8 2005 527 533
44. T. Amatsubo, D. Yanagisawa, and S. Morikawa Amyloid imaging using high-field magnetic resonance Magn Reson Med Sci 9 2010 95 99
45. 19F-containing curcumin derivative in a mouse model of Alzheimer's disease Neuroscience 184 2011 120 127
46. Y.Z. Wadghiri, J. Li, and J. Wang Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging PLoS ONE 8 2013 e57097
47. C.H. Fan, C.Y. Ting, and H.J. Lin SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery Biomaterials 34 2013 3706 3715